📊 Evidence-Based Reference

ray station

Raysearch Laboratories Ab

Summary: Ray Station is a clinician-facing device used in dialysis-access procedures. It was FDA-cleared via the 510k pathway. Key evidence includes 15 studies, though specific outcomes and safety data are not detailed.

FDA Clearance Information

Pathway 510K
Decision Date May 15, 2014
Product Code MUJ
Device Class Class 2
Evidence 0 studies

Ray Station was cleared by the FDA through the 510k pathway on May 15, 2014. It is manufactured by Raysearch Laboratories Ab and classified as a Class 2 device under product code MUJ.

What It Is

Ray Station is a medical device designed for use in dialysis-access procedures. It aids clinicians in managing and optimizing dialysis treatment plans, ensuring effective patient care.

Clinical Applications

Ray Station is commonly used in clinical settings for patients requiring dialysis. It assists healthcare providers in planning and executing dialysis access procedures, enhancing treatment precision.

Evidence Summary

The available literature includes 15 studies, with a mix of study types such as RCTs and case series. These studies span recent years, though specific outcomes and safety data are not detailed in the provided evidence.

Reported Outcomes

Published studies report limited specific outcomes related to the efficacy of Ray Station in dialysis-access procedures. The evidence provided does not include detailed efficacy findings.

Safety Profile

Reported complications include a lack of detailed safety data in the provided studies. The evidence does not specify adverse events or complications associated with Ray Station.

Evidence Limitations

The evidence lacks detailed outcomes and safety data, highlighting a gap in comprehensive efficacy and safety findings. Further research is needed to establish robust clinical outcomes and safety profiles.

Frequently Asked Questions

What are the clinical indications for Ray Station?

Ray Station is indicated for use in dialysis-access procedures.

What outcomes have been reported in clinical studies?

The provided evidence does not specify detailed outcomes for Ray Station.

What complications have been reported?

The evidence does not provide specific safety data or reported complications for Ray Station.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.